Replacing heart valves with prosthetic valves was, until recently, a complicated surgical procedure that involved cutting open the chest, establishing blood flow through a blood pump, stopping the heart, etc. This complicated procedure, even when performed perfectly, required extensive recovery time due to the invasiveness and damage done to access the implantation site. Additionally, the risk of infection or other complications is extremely high.
Numerous advancements have been made to develop prosthetic valves that can be implanted percutaneously, using a catheter to snake the prosthetic valve through the vasculature to the implantation site. If successful, the recovery time is greatly minimized relative to conventional open-heart surgery.
A designer of a percutaneously-delivered prosthetic valve is faced with numerous challenges, however. First and foremost is designing a prosthetic valve that can be compressed enough to be inserted into a catheter small enough to be navigated to the valve site through the vasculature. Other challenges include anchoring the valve at the valve site so the valve does not migrate after release; including a support structure for the valve that is robust enough to push the native, often calcified valve out of the way and prevent it from later interfering with the function of the new valve; ensuring that the new valve allows proper flow in a desired direction and effectively stops flow in the opposite direction; ensuring that no blood flows around the sides of the implanted device (this is known as perivalvular leakage); designing a prosthetic valve device that does not fail due to fatigue after hundreds of thousands of cycles of leaflet function; designing a valve that meets all of these criteria and can still be manufactured economically; and the list goes on.
These prosthetic valves, and their respective delivery catheters, are designed to replace a particular native valve, such as the aortic valve, for example. Percutaneous navigation to a valve is easiest, and least traumatic to the patient, when a smaller catheter is used. Smaller catheters, however, present challenges when designing effective prosthetic valves that can be compressed enough to fit, and slide, within the lumen of a small catheter, such as a 16 Fr or even a 14 Fr catheter. Significant strides have been made in recent years in designing prosthetic valves that have reduced profiles when in a catheter-loaded configuration. For example, the devices described in U.S. Patent Publication Number 2006/0271166 to Thill et al., the contents of which are incorporated by reference herein, can assume an elongated, unfolded configuration when loaded into a catheter and, when released from the catheter at a target site, resume a folded configuration. The present invention is directed to taking this innovative concept and presenting additional ways that the loaded configuration could present an even lower profile.
One aspect of the invention is directed to a prosthetic valve device that presents a low profile in a catheter-loaded configuration.
Another aspect of the invention is directed to a prosthetic valve device that is sized to replace an aortic valve and capable of being delivered using a small, flexible catheter.
Another aspect of the invention is directed to a prosthetic valve device that comprises two components are connected but positioned in series (spaced apart axially) in a delivery catheter to reduce the size of the delivery catheter required.
One aspect of the invention provides a device for replacing a native valve comprising: a stent; a tissue sleeve; and, an anchoring mechanism usable to secure said tissue sleeve within said stent; wherein, in a configuration inside a delivery catheter, said anchoring mechanism is not located within said stent; and wherein, in a deployed configuration, said tissue sleeve is located within said stent.
Another aspect of the invention provides prosthetic valve device that comprises a braided anchoring mechanism connected at a proximal end to a wireform.
Another aspect of the invention provides an implantable device that includes a support structure having an extended configuration and a folded configuration, the support structure having a first end, a second end and a preformed fold between said first end and said second end, wherein said preformed fold at least assists in inverting said first portion into said second portion when said support structure is released from a delivery device, and a prosthetic valve structure including a hinged end hingedly attached to said support structure first end, thereby allowing said support structure first portion to invert into said support structure second portion without inverting said prosthetic valve structure.
Another aspect of the invention provides an implantable prosthetic valve structure with a support structure that has a folded configuration in which the prosthetic valve structure extends, at least partially, into said support structure.
Another aspect of the invention provide a prosthetic valve device that includes a support structure that has inwardly curved sidewalls when it is in a folded configuration.
These and other aspects, features and advantages of which embodiments of the invention are capable of will be apparent and elucidated from the following description of embodiments of the present invention, reference being made to the accompanying drawings, in which
Specific embodiments of the invention will now be described with reference to the accompanying drawings. This invention may, however, be embodied in many different forms and should not be construed as limited to the embodiments set forth herein; rather, these embodiments are provided so that this disclosure will be thorough and complete, and will fully convey the scope of the invention to those skilled in the art. The terminology used in the detailed description of the embodiments illustrated in the accompanying drawings is not intended to be limiting of the invention. In the drawings, like numbers refer to like elements.
Referring first to
With regard to the support structure, a dotted line 22 represents a preformed fold created in the support structure 20 that at least partially causes the device 10 to fold inwardly on itself when released from a delivery catheter. The support structure 20 can be described as having a first end 24, a first portion 26 between the first end 24 and the preformed fold 22, a second end 30, and second portion 32 between the second end 30 and the preformed fold 22.
The valve assembly 40 includes tissue valve 42 attached to a wireform 40. The wireform 40 gives structural integrity to the tissue valve 44.
The connection 60 between the valve assembly 40 and the support structure 20 is described in more detail below.
Although the invention has been described in terms of particular embodiments and applications, one of ordinary skill in the art, in light of this teaching, can generate additional embodiments and modifications without departing from the spirit of or exceeding the scope of the claimed invention. Accordingly, it is to be understood that the drawings and descriptions herein are proffered by way of example to facilitate comprehension of the invention and should not be construed to limit the scope thereof.
This application is a continuation of U.S. patent application Ser. No. 14/212,442, filed Mar. 14, 2014, now U.S. Pat. No. 9,486,314, entitled Low-Profile Prosthetic Valve Structure which is related to and claims priority benefit of U.S. Provisional Application Ser. No. 61/800,153 filed Mar. 15, 2013 entitled Low-Profile Prosthetic Valve Structure, all of which are hereby incorporated by reference herein in their entireties.
Number | Name | Date | Kind |
---|---|---|---|
4056854 | Boretos et al. | Nov 1977 | A |
5549665 | Vesely et al. | Aug 1996 | A |
5669931 | Kupiecki et al. | Sep 1997 | A |
5843260 | Huskey | Dec 1998 | A |
5846261 | Kotula et al. | Dec 1998 | A |
6015431 | Thornton et al. | Jan 2000 | A |
6016810 | Ravenscroft | Jan 2000 | A |
6126686 | Badylak et al. | Oct 2000 | A |
6168614 | Andersen et al. | Jan 2001 | B1 |
6287335 | Drasler et al. | Sep 2001 | B1 |
6378028 | Inagawa et al. | Apr 2002 | B2 |
6402780 | Williamson, IV et al. | Jun 2002 | B2 |
6425916 | Garrison et al. | Jul 2002 | B1 |
6478028 | Paolitto et al. | Nov 2002 | B1 |
6524339 | Adams | Feb 2003 | B1 |
6592614 | Lenker et al. | Jul 2003 | B2 |
6605102 | Mazzocchi et al. | Aug 2003 | B1 |
6652578 | Bailey et al. | Nov 2003 | B2 |
6719781 | Kim | Apr 2004 | B1 |
6769434 | Liddicoat et al. | Aug 2004 | B2 |
6893457 | Dong | May 2005 | B2 |
6908481 | Cribier | Jun 2005 | B2 |
6929653 | Strecter | Aug 2005 | B2 |
7001425 | McCullagh et al. | Feb 2006 | B2 |
7252681 | Berg et al. | Aug 2007 | B2 |
7267686 | Dimatteo et al. | Sep 2007 | B2 |
7329279 | Haug et al. | Feb 2008 | B2 |
7445630 | Lashinski et al. | Nov 2008 | B2 |
3021420 | Dolan | Sep 2011 | A1 |
8157796 | Collins et al. | Apr 2012 | B2 |
8663312 | Wilson et al. | Mar 2014 | B2 |
8696737 | Gainor | Apr 2014 | B2 |
8845720 | Conklin | Sep 2014 | B2 |
8986374 | Cao et al. | Mar 2015 | B2 |
20020032481 | Gabbay | Mar 2002 | A1 |
20020128703 | Ravenscroft | Sep 2002 | A1 |
20030014104 | Cribier | Jan 2003 | A1 |
20040024416 | Yodfat et al. | Feb 2004 | A1 |
20040073293 | Thompson | Apr 2004 | A1 |
20040073301 | Donlon et al. | Apr 2004 | A1 |
20040093075 | Kuehne | May 2004 | A1 |
20040220664 | Chobotov | Nov 2004 | A1 |
20040260333 | Dubrul et al. | Dec 2004 | A1 |
20050022674 | Campbell et al. | Feb 2005 | A1 |
20050075720 | Nguyen et al. | Apr 2005 | A1 |
20050137691 | Salahieh et al. | Jun 2005 | A1 |
20050137702 | Haug et al. | Jun 2005 | A1 |
20050222674 | Paine | Oct 2005 | A1 |
20050240200 | Bergheim | Oct 2005 | A1 |
20050251251 | Cribier | Nov 2005 | A1 |
20050283231 | Haug et al. | Dec 2005 | A1 |
20060020327 | Lashinski et al. | Jan 2006 | A1 |
20060074484 | Huber | Apr 2006 | A1 |
20060142848 | Gabbay | Jun 2006 | A1 |
20060167468 | Gabbay | Jul 2006 | A1 |
20070010876 | Salahieh et al. | Jan 2007 | A1 |
20070203517 | Williams et al. | Aug 2007 | A1 |
20080015671 | Bonhoeffer | Jan 2008 | A1 |
20080071362 | Tuval et al. | Mar 2008 | A1 |
20080195199 | Kheradvar et al. | Aug 2008 | A1 |
20080300678 | Eidenschink et al. | Dec 2008 | A1 |
20090076598 | Salahieh et al. | Mar 2009 | A1 |
20090222076 | Figulla et al. | Sep 2009 | A1 |
20100161028 | Chuter | Jun 2010 | A1 |
20100168839 | Braido et al. | Jul 2010 | A1 |
20110218619 | Benichou et al. | Sep 2011 | A1 |
20110264206 | Tabor | Nov 2011 | A1 |
20110282439 | Thill et al. | Nov 2011 | A1 |
20120065728 | Gainor et al. | Mar 2012 | A1 |
20120209370 | Thill et al. | Aug 2012 | A1 |
20130144383 | Thill et al. | Jun 2013 | A1 |
20130204357 | Thill et al. | Aug 2013 | A1 |
20130204360 | Gainor | Aug 2013 | A1 |
20130282098 | Thill et al. | Oct 2013 | A1 |
20140155996 | Wilson et al. | Jun 2014 | A1 |
Number | Date | Country |
---|---|---|
2863503 | Aug 2013 | CA |
101991478 | Apr 2013 | CN |
102005052628 | May 2007 | DE |
1 915 105 | Apr 2008 | EP |
2 809 272 | Dec 2014 | EP |
2 967 861 | Jan 2016 | EP |
H0611637 | Jan 1994 | JP |
H1029161 | Feb 1998 | JP |
2000-291883 | Oct 2000 | JP |
2002-182095 | Jun 2002 | JP |
2002-228903 | Aug 2002 | JP |
2002-328317 | Nov 2002 | JP |
2002-537943 | Nov 2002 | JP |
2003-506133 | Feb 2003 | JP |
2003-098443 | Apr 2003 | JP |
2004-503327 | Feb 2004 | JP |
2007-237136 | Sep 2007 | JP |
4093401 | Jun 2008 | JP |
4549278 | Sep 2010 | JP |
5289049 | Sep 2013 | JP |
2014-000472 | Jan 2014 | JP |
2015-509033 | Mar 2015 | JP |
5749231 | Jul 2015 | JP |
2016-028783 | Mar 2016 | JP |
2016-064147 | Apr 2016 | JP |
1997027799 | Aug 1997 | WO |
1997030659 | Aug 1997 | WO |
1999015112 | Apr 1999 | WO |
2000053120 | Sep 2000 | WO |
2002005729 | Jan 2002 | WO |
2003092554 | Nov 2003 | WO |
2004082528 | Sep 2004 | WO |
2006036690 | Apr 2006 | WO |
2005058408 | Jun 2006 | WO |
2006083763 | Aug 2006 | WO |
2006128193 | Nov 2006 | WO |
2007051620 | May 2007 | WO |
2008072838 | Jun 2008 | WO |
2008097589 | Aug 2008 | WO |
2009153768 | Dec 2009 | WO |
2011143263 | Nov 2011 | WO |
WO 2012173995 | Dec 2012 | WO |
WO 2013078497 | Jun 2013 | WO |
2013116785 | Aug 2013 | WO |
WO 2014110019 | Jul 2014 | WO |
2014144020 | Sep 2014 | WO |
Number | Date | Country | |
---|---|---|---|
20170020667 A1 | Jan 2017 | US |
Number | Date | Country | |
---|---|---|---|
61800153 | Mar 2013 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14212442 | Mar 2014 | US |
Child | 15288543 | US |